ERIN STRAHAN: Open Payments
NPI 1396995890 · SHERIDAN, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 36 payments from 10 companies in 2025. Trend: 2023 $519 · 2024 $637 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $240 |
| Astellas Pharma US Inc | 4 | $114 |
| Lilly USA, LLC | 6 | $104 |
| Novo Nordisk Inc | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Insmed, Inc. | 2 | $53 |
| Amgen Inc. | 3 | $50 |
| ABBVIE INC. | 1 | $27 |
| IBSA Pharma Inc. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
Products named: BREZTRI, Veozah, MOUNJARO, TRELEGY ELLIPTA, Arikayce, EVENITY, QULIPTA, AIRSUPRA.
Industry payments across WY — which companies pay providers there.
